Martin Nutraceuticals products shown to help in cancer prevention
Recent studies suggest that curcumin an active ingredient in Martin Nutraceutical enzyme formulas, as in Arthrizyme(tm), are showing great promise in recent studies according to the journal "Cancer."
18/07/05 Martin Nutraceuticals Inc. Director of Research and Development, Dr. A.W. Martin, has announced that further studies indicate additional benefits from the use of Martin Nutraceuticals proprietary and patented products.
Martin Nutraceuticals patented oral enzyme formulas are showing great promise in cancer prevention. Recent studies suggest that curcumin an active ingredient in Martin Nutraceutical enzyme formulas, as in Arthrizyme(tm), are showing great promise in recent studies according to the journal "Cancer."
These studies have shown beneficial effects of curcumin on skin cancer, breast cancer and even on Alzheimer's. In the study quoted in the journal "Cancer," researchers treated melanoma cells lined with curcumin at different doses and for different durations. Researchers have found that the nuclear factor called Kappa-B is turned "on" in cancer cells. The study found that the nuclear factor called Kappa-B is turned "off" in cells that have been lined with curcumin.
Arthrizyme(tm) will be available shortly for major distribution.
